Radtke, Heather B. http://orcid.org/0000-0003-1557-7390
Klein-Tasman, Bonita P.
Merker, Vanessa L.
Knight, Pamela
Ullrich, Nicole J.
Jordan, Justin T.
Korf, Bruce
Plotkin, Scott R.
Article History
Received: 2 October 2020
Accepted: 21 January 2021
First Online: 1 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: HBR, PK, BPKT report no competing interests and the remaining authors report no competing interests related to this work. VLM is independent contractor for the Neurofibromatosis Network; JTJ receives consulting income from CereXis and Recursion pharmaceuticals, Navio Theragnostics, and Health2047, Inc. Royalties from Elsevier; BK is on the medical advisory board for Genome Medical, scientific advisory board for SpringWorks and has received support from AstraZeneca; and advisory board for Infixion; NJU was a one-time consultation lecturer for Astra Zeneca; SRP is a co-founder of NFlection therapeutics and NF2 Therapeutics; consultant for AstraZeneca and SonalaSense.